Company Performance Metrics
Lilly Australia develops and supplies prescription medicines as the Australian affiliate of Eli Lilly and Company. The company focuses on research-driven pharmaceutical products, including biologics and small-molecule therapies. Its portfolio addresses clinical areas such as type 2 diabetes, chronic weight management, oncology, immunology,
dermatology, migraine, and neurodegenerative diseases including Alzheimer’s disease. Lilly Australia supports local clinical trials, collaborates on regulatory submissions, and manages commercialization activities for its medicines. It also provides information resources on specific conditions and treatment options for patients and healthcare professionals. Through these activities, Lilly Australia concentrates on bringing new and existing therapies to the Australian market under appropriate regulatory oversight.
